Edition:
United States

Aimmune Therapeutics Inc (AIMT.OQ)

AIMT.OQ on NASDAQ Stock Exchange Global Select Market

37.20USD
16 Feb 2018
Change (% chg)

-- (--)
Prev Close
$37.20
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
169,580
52-wk High
$40.62
52-wk Low
$15.97

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.630
Jun '17 0.00 -0.647
Mar '17 0.00 -0.517
FY 2016 Dec '16 0.00 -0.551
Sep '16 0.00 -0.526
Jun '16 0.00 -0.434
Mar '16 0.00 -0.372
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 6 0.00 0.00 0.00 0.00
Quarter Ending Jun-18 6 0.00 0.00 0.00 0.00
Year Ending Dec-18 8 0.00 0.00 0.00 19.87
Earnings (per share)
Quarter Ending Mar-18 6 -0.72 -0.59 -0.86 --
Quarter Ending Jun-18 6 -0.73 -0.60 -0.88 --
Year Ending Dec-18 9 -3.11 -2.33 -3.67 -2.55
LT Growth Rate (%) 1 34.60 34.60 34.60 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 32.45 35.76
P/E High - Last 5 Yrs. -- 41.44 46.66
P/E Low - Last 5 Yrs. -- 23.40 24.18
Beta -- 0.81 0.81
Price to Sales (TTM) -- 6.28 8.59
Price to Book (MRQ) 8.96 4.38 5.23
Price to Tangible Book (MRQ) 8.98 4.85 6.37
Price to Cash Flow (TTM) -- 23.23 26.13
% Owned Institutions 82.90 1.25 2.31

Dividends

  Company industry sector
Dividend Yield -- 1.58 1.50
Dividend Yield - 5 Year Avg -- 2.15 2.01
Dividend 5 Year Growth Rate -- 4.24 5.25
Payout Ratio(TTM) -- 45.34 44.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 8.71 9.62
Sales (TTM) vs TTM 1 Yr. Ago -- 6.38 7.31
Sales - 5 Yr. Growth Rate -- 9.89 10.20
EPS (MRQ) vs Qtr. 1 Yr. Ago -19.81 14.84 18.60
EPS (TTM) vs TTM 1 Yr. Ago -36.73 -- --
EPS - 5 Yr. Growth Rate -- 10.37 11.47
Capital Spending - 5 Yr. Growth Rate -- 14.63 14.75

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.39 2.43
Current Ratio (MRQ) 10.29 3.34 3.39
LT Debt to Equity (MRQ) 0.00 9.12 11.95
Total Debt to Equity (MRQ) 0.00 12.31 15.32
Interest Coverage (TTM) -- 44.69 38.67

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.21 54.89
Gross Margin - 5 Yr. Avg. -- 52.54 52.59
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.58 10.03
Operating Margin (TTM) -- 11.50 2.96
Operating Margin - 5 Yr. Avg. -- 14.39 5.27
Pre-Tax Margin (TTM) -- 11.87 3.78
Pre-Tax Margin - 5 Yr. Avg. -- 14.67 5.53
Net Profit Margin (TTM) -- 8.25 0.26
Net Profit Margin - 5 Yr. Avg. -- 10.98 1.79
Effective Tax Rate (TTM) -- 22.40 22.06
Effective Tax Rate - 5 Yr. Avg. -- 23.58 24.20

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 924,682,765 824,372,705
Net Income/Employee (TTM) -1,670,073 108,239,788 96,444,553
Receivable Turnover (TTM) -- 5.30 5.41
Inventory Turnover (TTM) -- 2.60 3.49
Asset Turnover (TTM) 0.00 0.93 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -56.57 11.15 10.73
Return on Assets - 5 Yr. Avg. -- 12.66 12.02
Return on Investment (TTM) -61.56 14.04 13.59
Return on Investment - 5 Yr. Avg. -- 16.57 15.73
Return on Equity (TTM) -62.11 15.50 15.20
Return on Equity - 5 Yr. Avg. -- 17.65 16.95
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -0.51 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aimmune Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -4.37 -1.64 99 66
13 Week 6.44 0.46 99 44
26 Week 95.07 73.18 99 18
52 Week 85.26 59.15 99 28
YTD -1.64 -3.75 99 40
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 82.90%
# of Holders: 180
Total Shares Held: 42,164,621
3 Mo. Net Change: -1,449,241
# New Positions: 45
# Closed Positions: 10
# Increased Positions: 94
# Reduced Positions: 61
# Net Buyers: 33
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.